We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Kbw Regional Banking Index | DOWI:KRX | Dow Jones Indices | Index |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0 | - |
Keryx Biopharmaceuticals, Inc. News NEW YORK, Dec. 19 -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX; AIM: KRX), today announced that application has been made for block admission to trading on AIM for 755,883 shares of common stock par value $0.001 per share in Keryx Biopharmaceuticals, Inc. ("Keryx"). The shares may be issued upon the exercise of warrants granted in conjunction with the private placement of shares of Keryx common stock announced on 18 November 2003. The warrants bear an exercise price of $6.00 per warrant. KERYX CONTACT: Ron Bentsur VP Finance and Investor Relations Keryx Biopharmaceuticals, Inc. Tel: +1-212-531-5965 E-mail: ron@keryx.com SOURCE Keryx Biopharmaceuticals, Inc. -0- 12/19/2003 /CONTACT: Ron Bentsur, VP Finance and Investor Relations of Keryx Biopharmaceuticals, Inc., +1-212-531-5965, ron@keryx.com / END
1 Year Kbw Regional Banking Index Chart |
1 Month Kbw Regional Banking Index Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions